Health care stocks fell premarket Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.7% lower and the iShares Biotechnology ETF (IBB) recently down 0.4%.
CEL-SCI (CVM) shares declined by over 45% after the company priced an offering of 2 million shares at $2.50 apiece, targeting gross proceeds of $5 million.
Sanofi (SNY) has agreed to acquire Vigil Neuroscience (VIGL) in a cash transaction with an equity value of up to $600 million, the companies said. Shares of Vigil Neuroscience surged 242% pre-bell.
Eli Lilly (LLY) said the Australian Therapeutic Goods Administration granted marketing authorization for Kisunla, an injection for intravenous infusion given every four weeks to treat mild cognitive impairment and mild dementia due to Alzheimer's disease. Shares of Eli Lilly were over 1% lower pre-bell.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。